Table:
begin	end	state
1	5	non-cytoplasmic
6	25	transmembrane
26	36	cytoplasmic
37	56	transmembrane
57	75	non-cytoplasmic
76	98	transmembrane
99	118	cytoplasmic
119	141	transmembrane
142	150	non-cytoplasmic
151	173	transmembrane
174	184	cytoplasmic
185	205	transmembrane
206	226	non-cytoplasmic
227	246	transmembrane
247	266	cytoplasmic
267	290	transmembrane
291	310	non-cytoplasmic
311	336	transmembrane
337	359	cytoplasmic
360	377	transmembrane
378	388	non-cytoplasmic
389	407	transmembrane
408	413	cytoplasmic
414	433	transmembrane
434	438	non-cytoplasmic
439	460	transmembrane
461	474	cytoplasmic

Input:
>5210844 FitnessBrowser__PV4:5210844
MEQTIQVAIFVALTTLVALITYLKCRKVTRDANDSRDYFLAGGGLSWIVVAGSLMMTNIS
AEQIVGMNGAQTLLVAWWEIAAAIGLIILAKWLIPIYYRYNCTTTTELLERKYQDKGIRA
MVSLLFMLGYAFILLPVVLYTGSLFMKSMFGLSISVTVLAIIFAVVGAIYAIFGGLRAIA
ISDTLNGLGLILMGLAVSYLAMHAVDWDLSGIPLERLTLIGDSQSDIPWSTLLTGMIFIQ
IFYWGTNMVITQRALAAKSVKEAQKGLYAAVVMKLIIPVIVVLPGIVAFKLYGDVGDVAY
GKLVGDLLPSWLSGAFAAVIAGAVLSSFNSCLNSAAALYTCDIHQNYINADADVRKIGSR
VALLFTLISVALVPLFARSESIIALLQQLNGLYSMPVLAAFICALVFKNVSAKAIKWGLV
FGVLLYALFTFIWSPLHFIHLMAITLLATILVTLVFSRLFAQPVIAPVAEPTLD

Or try the official Phobius web server, which has a different display

Reference: Advantages of combined transmembrane topology and signal peptide prediction - the Phobius web server